Media formats available:

Encore Dermatology Introduces HylatopicPlus Lotion

Encore Dermatology, Inc. expanded its line with the introduction of HylatopicPlus Lotion in a 14oz. bottle with pump dispenser. The prescription product relieves the burning, itching and pain experienced with various types of skin conditions, including atopic dermatitis, allergic contact dermatitis, and radiation dermatitis. HylatopicPlus Lotion also helps alleviate dry, waxy skin by maintaining a moist wound and skin environment. The HylatopicPlus product line includes HylatopicPlus Cream and HylatopicPlus Emollient Foam.

Biofrontera Launches Ameluz for Actinic Keratosis

Biofrontera AG launched its combination topical prescription drug Ameluz and medical device BF-RhodoLED, which has been FDA approved to treat mild to moderate actinic keratosis (AK) on the face and scalp. Ameluz is used in combination with the medical device BF-RhodoLED for photodynamic therapy treatment (PDT). FDA approval of the combination treatment covers lesion-directed and field-directed treatment of AK. After field-directed treatment with Ameluz, patients benefit from the long-lasting skin rejuvenation effect demonstrated in Biofrontera’s phase III trials.

New ProSystem Retinol Peel from NeoStrata

NeoStrata introduced the NeoStrata ProSystem Retinol Peel, the first retinol peel for the brand. The peel contains 3% Retinol plus Retinol Boosting Complex to exfoliate and improve the appearance of fine lines and wrinkles, help reduce acne, and improve skin laxity while promoting a bright, even, and clear complexion. Other ingredients include neoCitriate, which targets collagen; aminofil, a novel amino acid derivative that helps enhances collagen and hyaluronic acid; bisabolol, a botanical derived from chamomile that helps calm skin; and the powerful antioxidant Vitamin E. The peel is applied in-office, then washed off at home after eight hours or overnight wear. It does not discolor skin, but patients can expect moderate flaking for three to five days as old, dull layers of skin are shed. For best results, the peel is recommended to be repeated every six to eight weeks.

Burke Thearpeutics Introduces Entty Spray Emulsion

Burke Therapeutics launched Entty Spray Emulsion, the only spray emollient on the market indicated for atopic dermatitis and eczema. It contains sodium hyaluronate and African palm oil and is safe for use in all ages. Entty is steroid-, paraben-, sulfate-, petrolatum-, phthalate-, and dye-free, and relieves the burning and itching experienced with various types of dermatoses. It helps maintain a moist wound and skin environment, which is beneficial to the healing process. Available by prescription only, Entty Spray Emulsion comes in a 250mL bottle. To request samples or visit with a rep please call (501) 620-4449.

Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free